Search research articles
Contact Us
Filters
Showing results (1-10 of 378) with videos related to
Page
of 38
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 24, 2020
Opioid-sparing effects of cannabinoids: Myth or reality?
Bernard Le Foll
Progress in Brain Research
|
January 30, 2016
What does addiction medicine expect from neuroscience? From genes and neurons to treatment responses
Bernard Le Foll
Trends in Psychiatry and Psychotherapy
|
January 26, 2022
Monitoring the impact of cannabis use
Bernard Le Foll
Focus (American Psychiatric Publishing)
|
February 6, 2020
Psychosocial and Pharmacological Interventions for the Treatment of Cannabis Use Disorder
Pamela Sabioni, Bernard Le Foll
Expert Opinion on Drug Discovery
|
May 20, 2020
Novel therapeutic and drug development strategies for tobacco use disorder: endocannabinoid modulation
Kevin Butler, Bernard Le Foll
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 13, 2019
The complexity of pharmacology of cannabidiol (CBD) and its implications in the treatment of brain disorders
Sonja Elsaid, Bernard Le Foll
Frontiers in Psychiatry
|
March 19, 2019
Impact of Substance Use Disorder Pharmacotherapy on Executive Function: A Narrative Review
Kevin Butler, Bernard Le Foll
Expert Review of Respiratory Medicine
|
August 11, 2018
Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment
Nikki Bozinoff, Bernard Le Foll
Current Topics in Behavioral Neurosciences
|
April 25, 2022
A Historical Perspective on the Dopamine D3 Receptor
Pierre Sokoloff, Bernard Le Foll
The Medical Clinics of North America
|
June 24, 2018
When and How to Treat Possible Cannabis Use Disorder
Annie Lévesque, Bernard Le Foll
Page
of 38
Search research articles
Search
Showing results (1-10 of 378) with videos related to
Sort By:
Page
of 38
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 24, 2020
Opioid-sparing effects of cannabinoids: Myth or reality?
Bernard Le Foll
Progress in Brain Research
|
January 30, 2016
What does addiction medicine expect from neuroscience? From genes and neurons to treatment responses
Bernard Le Foll
Trends in Psychiatry and Psychotherapy
|
January 26, 2022
Monitoring the impact of cannabis use
Bernard Le Foll
Focus (American Psychiatric Publishing)
|
February 6, 2020
Psychosocial and Pharmacological Interventions for the Treatment of Cannabis Use Disorder
Pamela Sabioni, Bernard Le Foll
Expert Opinion on Drug Discovery
|
May 20, 2020
Novel therapeutic and drug development strategies for tobacco use disorder: endocannabinoid modulation
Kevin Butler, Bernard Le Foll
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
September 13, 2019
The complexity of pharmacology of cannabidiol (CBD) and its implications in the treatment of brain disorders
Sonja Elsaid, Bernard Le Foll
Frontiers in Psychiatry
|
March 19, 2019
Impact of Substance Use Disorder Pharmacotherapy on Executive Function: A Narrative Review
Kevin Butler, Bernard Le Foll
Expert Review of Respiratory Medicine
|
August 11, 2018
Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment
Nikki Bozinoff, Bernard Le Foll
Current Topics in Behavioral Neurosciences
|
April 25, 2022
A Historical Perspective on the Dopamine D3 Receptor
Pierre Sokoloff, Bernard Le Foll
The Medical Clinics of North America
|
June 24, 2018
When and How to Treat Possible Cannabis Use Disorder
Annie Lévesque, Bernard Le Foll
Page
of 38